To minimize fetal bradycardia during reversal of neuromuscular blockade in obstetric patients, which combination is preferred?

To minimize fetal bradycardia during reversal of neuromuscular blockade in obstetric patients, which combination is preferred?

• A. Neostigmine with glycopyrrolate
• B. Neostigmine with atropine
• C. Edrophonium with atropine
• D. Sugammadex

Answer: (B)

The key idea is how to counteract the muscarinic effects that come with reversing a residual neuromuscular blockade, and how this affects the fetus in obstetric patients. Reversing with a cholinesterase inhibitor increases acetylcholine at muscarinic receptors, which can cause bradycardia. To prevent this, an antimuscarinic is given alongside. Among antimuscarinics, atropine crosses the placenta readily, so it can block fetal muscarinic receptors as well as maternal ones. This provides fetal protection against bradycardia during reversal. Glycopyrrolate, while gentler on the mother and less likely to cause central effects, has limited placental transfer, offering less protection to the fetus. In obstetric care, protecting the fetus from bradycardia is a priority, making neostigmine paired with atropine the preferred combination. Edrophonium is another acetylcholinesterase inhibitor but is less commonly used nowadays, and sugammadex reverses rocuronium without relying on muscarinic pathways, but practice patterns and safety data in pregnancy also influence its use.

The key idea is how to counteract the muscarinic effects that come with reversing a residual neuromuscular blockade, and how this affects the fetus in obstetric patients. Reversing with a cholinesterase inhibitor increases acetylcholine at muscarinic receptors, which can cause bradycardia. To prevent this, an antimuscarinic is given alongside.

Among antimuscarinics, atropine crosses the placenta readily, so it can block fetal muscarinic receptors as well as maternal ones. This provides fetal protection against bradycardia during reversal. Glycopyrrolate, while gentler on the mother and less likely to cause central effects, has limited placental transfer, offering less protection to the fetus. In obstetric care, protecting the fetus from bradycardia is a priority, making neostigmine paired with atropine the preferred combination.

Edrophonium is another acetylcholinesterase inhibitor but is less commonly used nowadays, and sugammadex reverses rocuronium without relying on muscarinic pathways, but practice patterns and safety data in pregnancy also influence its use.